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The aim of this work is the evaluation of the current situation in the clinical study of 
medication, description of the rights and the protection of the subject of evaluation in the 
research and solution of selected questions, which may be confusing or at least unclear for the 
average person. Furthermore, this thesis discusses the exercise of the rights of the subject of the 
research with focus on damages incurred by the subject of evaluation and to his close persons. 
The last question is payment for participation in clinical research and other benefits that the 
subject of the evaluation gains for the participation. 
Through this methodology, this work has resulted in a detailed analysis of the rights of 
the subject, especially in relation to his / hers personal rights, their protection and performance. 
Through the method described above, it brings a new perspective on the relationship of liability 
for the damage caused to the subject of the clinical research. It also presents arguments pointing 
to the necessity to change the actual but legally unsatisfactory status of the reimbursements 
provided for participation in the clinical research. 
The main findings of this work are the clarification of the liability in relationships that 
arise in clinical research. They are essentially the objective liability of the contract owner and, in 
most cases, the subjective responsibility of the healthcare provider and the description of the 
practically provided remittances; the questions why the research needs to be provided and why 
the current legislation is inadequate are answered. 
The thesis is solved within the current legal regulation in the context of European and 
international law with a short historical perspective on the development of the legal regulation of 
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